Similar articles

• Transplantation: sirolimus plus calcineurin inhibitors in transplantation.

  Braun W. Braun W. Nat Rev Nephrol. 2009 May;5(5):252-4. doi: 10.1038/nrneph.2009.55. Nat Rev Nephrol. 2009. PMID: 19384324
• [Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].

  Arns W, Budde K, Eitner F, Gwinner W, Hugo C, Pressmar K, Weimann A, Witzke O. Arns W, et al. Dtsch Med Wochenschr. 2011 Dec;136(49):2554-9. doi: 10.1055/s-0031-1292822. Epub 2011 Nov 30. Dtsch Med Wochenschr. 2011. PMID: 22131077 German. No abstract available.
• Transplantation: To convert or not to convert: lessons from the CONVERT trial.

  Bunnapradist S, Vincenti F. Bunnapradist S, et al. Nat Rev Nephrol. 2009 Jul;5(7):371-3. doi: 10.1038/nrneph.2009.94. Nat Rev Nephrol. 2009. PMID: 19556993
• Sirolimus: not so sparing in the Spare-the-Nephron trial.

  Shamseddin MK, Gupta A. Shamseddin MK, et al. Kidney Int. 2011 Jun;79(12):1379; author reply 1379-80. doi: 10.1038/ki.2011.88. Kidney Int. 2011. PMID: 21625260 No abstract available.
• Sirolimus: a new option in transplantation.

  Mota A. Mota A. Expert Opin Pharmacother. 2005 Mar;6(3):479-87. doi: 10.1517/14656566.6.3.479. Expert Opin Pharmacother. 2005. PMID: 15794738 Review.